Watch replays of the main stage programming from the SOSV Climate Tech Summit (Nov. 5-6)

Neurotechnology for Women's Health Needs

Team

Alex Cook

Co-Founder

Emilė Radytė

Co-Founder

Samphire Neuroscience

Company details

Samphire Neuroscience builds neurotechnology for neglected areas of women’s chronic health. Their first product, Nettle, is a medically-certified brain stimulating wearable that reduces pain and improves PMS symptoms for women of reproductive age, including patients with endometriosis, severe PMS (PMDD), uterine fibroids and beyond. Samphire has demonstrated initial commercial PMF validation following their clinical trials and regulatory certifications, and are looking to enter the US and grow in the EU next.

Get In Touch with Samphire Neuroscience

Please tell us a little bit about yourself and why you'd like to get connected. Samphire Neuroscience + SOSV will follow up with you via email.

Hidden
Hidden
Hidden
Hidden
Opt-in checkbox


We don’t spam. Our Privacy Policy and Terms of Use apply.
* If you are interested in investing directly into SOSV's portfolio of privately held companies, or into SOSV's funds, you need to meet the SEC’s criteria for accredited investor status. As an individual, you can qualify as an accredited investor by either (a) having more than $200,000 in annual income for each of the past two years (or $300,000 with your spouse) and a reasonable expectation of earning the same this year or (b) having a net worth of at least $1 million (not including your principal residence). Learn More